7D4G

A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2

Summary for 7D4G

• Entry DOI: 10.2210/pdb7d4g/pdb
• EMDB information: 30573
• Descriptor: Spike glycoprotein S1, Light chain of FC05 Fab, Heavy chain of FC05 Fab (3 entities in total)
• Functional Keywords: sars-cov-2, spike, antibody, viral protein
• Biological source: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV); More
• Total number of polymer chains: 3
• Total formula weight: 56473.02

Authors

Cao, L.,Wang, X. (deposition date: 2020-09-23, release date: 2021-04-07, Last modification date: 2022-02-23)

• Primary citation: Zhang, L.,Cao, L.,Gao, X.S.,Zheng, B.Y.,Deng, Y.Q.,Li, J.X.,Feng, R.,Bian, Q.,Guo, X.L.,Wang, N.,Qiu, H.Y.,Wang, L.,Cui, Z.,Ye, Q.,Chen, G.,Lu, K.K.,Chen, Y.,Chen, Y.T.,Pan, H.X.,Yu, J.,Yao, W.,Zhu, B.L.,Chen, J.,Liu, Y.,Qin, C.F.,Wang, X.,Zhu, F.C.; A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2.; Natl Sci Rev, 8:nwab053-nwab053, 2021; PubMed: 34676098; DOI: 10.1093/nsr/nwab053

Experimental method

ELECTRON MICROSCOPY (3.9 Å)